Projects per year
Fingerprint
Dive into the research topics where Matthew Philip Goetz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3
Goetz, M. P., Toi, M., Huober, J., Sohn, J., Trédan, O., Park, I. H., Campone, M., Chen, S. C., Manso, L. M., Paluch-Shimon, S., Freedman, O. C., O'Shaughnessy, J., Pivot, X., Tolaney, S. M., Hurvitz, S. A., Llombart-Cussac, A., André, V., Saha, A., van Hal, G. & Shahir, A. & 2 others, , Aug 2024, In: Annals of Oncology. 35, 8, p. 718-727 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes
Rastogi, P., O'shaughnessy, J., Martin, M., Boyle, F., Cortes, J., Rugo, H. S., Goetz, M. P., Hamilton, E. P., Huang, C. S., Senkus, E., Tryakin, A., Cicin, I., Testa, L., Neven, P., Huober, J., Shao, Z., Wei, R., André, V., Munoz, M. & San Antonio, B. & 3 others, , Mar 20 2024, In: Journal of Clinical Oncology. 42, 9, p. 987-993 7 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Anastrozole Dose Escalation for Optimal Estrogen Suppression in Postmenopausal Early-Stage Breast Cancer: A Prospective Trial
Haddad, T. C., Suman, V. J., Giridhar, K. V., Sideras, K., Northfelt, D. W., Ernst, B. J., O’Sullivan, C. C., Singh, R. J., Desta, Z., Peethambaram, P. P., Hobday, T. J., Chumsri, S., Leon-Ferre, R. A., Ruddy, K. J., Yadav, S., Taraba, J. L., Goodnature, B., Goetz, M. P., Wang, L. & Ingle, J. N., Aug 1 2024, In: Clinical Cancer Research. 30, 15, p. 3147-3156 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Automated mitotic spindle hotspot counts are highly associated with clinical outcomes in systemically untreated early-stage triple-negative breast cancer
Leon-Ferre, R. A., Carter, J. M., Zahrieh, D., Sinnwell, J. P., Salgado, R., Suman, V. J., Hillman, D. W., Boughey, J. C., Kalari, K. R., Couch, F. J., Ingle, J. N., Balkenhol, M., Ciompi, F., van der Laak, J. & Goetz, M. P., Dec 2024, In: npj Breast Cancer. 10, 1, 25.Research output: Contribution to journal › Article › peer-review
Open Access -
Blockade of tumor cell-intrinsic PD-L1 signaling enhances AURKA-targeted therapy in triple negative breast cancer
Takchi, A., Zhang, M., Jalalirad, M., Ferre, R. L., Shrestha, R., Haddad, T., Sarkaria, J., Tuma, A., Carter, J., David, H., Giridhar, K., Wang, L., Lange, C., Lendahl, U., Ingle, J., Goetz, M. & D’Assoro, A. B., 2024, In: Frontiers in Oncology. 14, 1384277.Research output: Contribution to journal › Article › peer-review
Open Access